Federal Register / Vol. 73, No. 109 / Thursday, June 5, 2008 / Notices 32029 

person. The hours burden imposed by 

the pretest will be approximately 8.5 

hours (100 respondents 5 minutes for 

each). 

The FTC staff estimates that the 

survey of 1,000 respondents also will 

require no more than 5 minutes per 

person or 83.5 hours (1,000 respondents 

5 minutes for each). 

Thus, the estimated total hours 

burden attributable to the telephone 

survey research is 242 hours (150 + 8.5 

+ 83.5). 

The combined total hours burden 

attributable to both research projects is 

378.5 hours (242 + 136.5). 

3. Estimated Cost Burden 

The cost per respondent should be 

negligible. Participation is voluntary 

and will not require any labor 

expenditures by respondents nor 

capital, start-up, operation, 

maintenance, or other similar costs. 

William Blumenthal 

General Counsel 

[FR Doc. E8–12590 Filed 6–4–08: 8:45 am] 

[Billing code: 6750–01–S] 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the National Biodefense 

Science Board 

AGENCY: Department of Health and 

Human Services, Office of the Secretary. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services is hereby giving notice that the 

National Biodefense Science Board 

(NBSB) will be holding a meeting. The 

meeting is open to the public. 

DATES: The meeting will be held on June 

18, 2008, from 8:30 a.m. to 5 p.m. 

ADDRESSES: The Sheraton National 

Hotel, 900 S. Orme Street, Arlington, 

VA 22204. Phone: 703–521–1900. 

FOR FURTHER INFORMATION, CONTACT: 

CAPT Leigh A. Sawyer, D.V.M., M.P.H., 

Executive Director, National Biodefense 

Science Board, Office of the Assistant 

Secretary for Preparedness and 

Response, U.S. Department of Health 

and Human Services, 200 Independence 

Ave SW., Room 638G, Washington, DC 

20201; 202–205–3815; fax: 202–205–

0613; e-mail address: 

leigh.sawyer@hhs.gov. 

SUPPLEMENTARY INFORMATION: Pursuant 

to section 319M of the Public Health 

Service Act (42 U.S.C. 247d–7f) and 

section 222 of the Public Health Service 

Act (42 U.S.C. 217a), the Department of 

Health and Human Services established 

the National Biodefense Science Board. 

The Board shall provide expert advice 

and guidance to the Secretary on 

scientific, technical, and other matters 

of special interest to the Department of 

Health and Human Services regarding 

current and future chemical, biological, 

nuclear, and radiological agents, 

whether naturally occurring, accidental, 

or deliberate. The Board may also 

provide advice and guidance to the 

Secretary on other matters related to 

public health emergency preparedness 

and response. 

Topics to be discussed include 

updates from the Pandemic Influenza 

Working Group, the Disaster Medicine 

Working Group, the Markets and 

Sustainability Working Group, and the 

U.S. Medical Countermeasure Research 

and Development Processes for 

Chemical, Biological, Radiological and 

Nuclear Agents Working Group. 

Additionally, the NBSB will discuss 

preparedness and planning issues 

related to at-risk populations and 

pandemic influenza , consider issues 

related to medical response and 

preparedness for radiological and 

nuclear events, and receive an update 

on the activities of the Homeland 

Security Presidential Directive #21, 

Federal Biosurveillance Working Group. 

The NBSB will also receive a briefing on 

issues related to the Department of 

Health and Human Services 

development of MedKits. This agenda is 

subject to change as priorities dictate. A 

tentative schedule will be made 

available on June 6, 2008 at the NBSB 

Web site, http://www.hhs.gov/aspr/ 

omsph/nbsb. 

Any member of the public interested 

in presenting oral comments at the 

meeting may notify the Contact person 

listed on this notice by June 11, 2008. 

Interested individuals and 

representatives of an organization may 

submit a letter of intent and a brief 

description of the organization 

represented. In addition, any interested 

person may file written comments with 

the committee. All written comments 

must be received prior to June 11, 2008 

and should be sent by e-mail with 

‘‘NBSB Public Comment’’ as the subject 

line or by regular mail to the Contact 

person listed above. Individuals who 

plan to attend and need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, should notify the 

designated contact person. 

Dated: May 30, 2008. 

RADM William C. Vanderwagen, 

Assistant Secretary for Preparedness and 

Response, U.S. Department of Health and 

Human Services. 

[FR Doc. 08–1321 Filed 6–2–08; 2:27pm] 

BILLING CODE 4150–37–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2005–N–0474] (formerly 

Docket No. 2005N–0210) 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Veterinary Feed 

Directive 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension of an existing collection of 

information, and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

reporting and recordkeeping 

requirements for distribution and use of 

Veterinary Feed Directive drugs and 

animal feeds containing Veterinary Feed 

Directive drugs. 

DATES: Submit written or electronic 

comments on the collection of 

information by August 4, 2008. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to http:// 

www.regulations.gov. Submit written 

comments on the collection of 

information to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. All 

comments should be identified with the 

docket number found in brackets in the 

heading of this document. 

FOR FURTHER INFORMATION CONTACT: 

Denver Presley, Jr., Office of the Chief 

Information Officer (HFA–250), Food 

and Drug Administration, 5600 Fishers 

Lane, Rockville, MD 20857, 301–827–

1472. 

SUPPLEMENTARY INFORMATION: Under the 

PRA (44 U.S.C. 3501–3520), Federal 

agencies must obtain approval from the 


yshivers on PROD1PC62 with NOTICES